Filing Details

Accession Number:
0001493152-24-036127
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-09-13 09:10:53
Reporting Period:
2023-09-29
Accepted Time:
2024-09-13 09:10:53
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1922335 Syra Health Corp SYRA Services-Employment Agencies (7361) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1962000 Priya Prasad C/O Syra Health Corp.
1119 Keystone Way N., #201
Carmel IN 46032
Cfo And Coo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Class A Common Stock Acquisiton 2023-09-29 918 $3.30 918 No 4 P Indirect See footnote
Class A Common Stock Acquisiton 2023-10-03 2,400 $0.00 3,318 No 4 P Indirect See footnote
Class A Common Stock Disposition 2023-10-05 918 $3.19 2,400 No 4 S Indirect See footnote
Class A Common Stock Acquisiton 2023-10-09 1,000 $2.66 3,400 No 4 P Indirect See footnote
Class A Common Stock Acquisiton 2023-12-01 435 $1.23 3,835 No 4 P Indirect See footnote
Class A Common Stock Acquisiton 2023-12-04 4,271 $1.14 8,106 No 4 P Indirect See footnote
Class A Common Stock Disposition 2023-12-04 735 $1.15 7,371 No 4 S Indirect See footnote
Class A Common Stock Acquisiton 2023-12-05 10 $1.21 7,381 No 4 P Indirect See footnote
Class A Common Stock Disposition 2023-12-05 2,000 $1.31 5,381 No 4 S Indirect See footnote
Class A Common Stock Acquisiton 2023-12-06 50 $1.22 5,431 No 4 P Indirect See footnote
Class A Common Stock Acquisiton 2023-12-07 10 $1.22 5,441 No 4 P Indirect See footnote
Class A Common Stock Acquisiton 2023-12-08 50 $1.23 5,491 No 4 P Indirect See footnote
Class A Common Stock Acquisiton 2023-12-21 1 $1.18 5,492 No 4 P Indirect See footnote
Class A Common Stock Disposition 2024-02-08 500 $7.50 4,992 No 4 S Indirect See footnote
Class A Common Stock Acquisiton 2024-09-12 5,303 $0.38 10,295 No 4 P Indirect See footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect See footnote
No 4 P Indirect See footnote
No 4 S Indirect See footnote
No 4 P Indirect See footnote
No 4 P Indirect See footnote
No 4 P Indirect See footnote
No 4 S Indirect See footnote
No 4 P Indirect See footnote
No 4 S Indirect See footnote
No 4 P Indirect See footnote
No 4 P Indirect See footnote
No 4 P Indirect See footnote
No 4 P Indirect See footnote
No 4 S Indirect See footnote
No 4 P Indirect See footnote
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Class A Common Stock Class A Common Stock Warrants (right to buy) Acquisiton 2023-10-03 2,400 $0.00 2,400 $6.50
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
2,400 2023-10-03 2028-10-03 No 4 P Indirect
Footnotes
  1. Held beneficially by the spouse of the Reporting Person.
  2. The reported securities are included within 2,400 units ("Units") purchased by the spouse of the Reporting Person for $4.125 per Unit. Each Unit consists of: (i) one share of Class A Common Stock and (ii) one warrant to purchase one share of Class A Common Stock at an exercise price equal to $6.50 per share, exercisable until the fifth anniversary of the issuance date.
  3. This purchase price reflects a weighted average of multiple prices ranging from $1.20 to $1.28. Full information regarding the number of shares purchased at each price will be provided to the Securities and Exchange Commission staff, the Issuer or any security holder of the Issuer upon request.
  4. This purchase price reflects a weighted average of multiple prices ranging from $1.05 to approximately $1.21. Full information regarding the number of shares purchased at each price will be provided to the Securities and Exchange Commission staff, the Issuer or any security holder of the Issuer upon request.
  5. This sales price reflects a weighted average of multiple prices ranging from $1.12 to $1.15. Full information regarding the number of shares sold at each price will be provided to the Securities and Exchange Commission staff, the Issuer or any security holder of the Issuer upon request.